Clinical Trials Logo

Clinical Trial Summary

The main objective of this study was to validate the clinical effectiveness of interbody fusion with a one-segment extension for the treatment of adjacent segmental space discs in the surgical treatment of lumbar degeneration.


Clinical Trial Description

The study will include patients with lumbar degeneration who underwent 1-2 segment interbody fusion, and for patients with vacuum signs but no symptoms and no instability of the discs in the adjacent segments of the operated segments, lumbar interbody fusion will be extended by one segment, and the patients will be followed up annually in the immediate postoperative period, in March, June, and in the period of 1-5 years, and lumbar MR will be taken at the time of follow-up to determine the degree of progression of the degeneration in the neighboring segments, and whether or not revision surgery is needed. The lumbar spine was photographed in the frontal and lateral + anterior flexion and posterior extension X-rays and CT-3D reconstruction to determine the bony fusion of the interbody fusion. In addition, the lumbar spine ODI score was applied for evaluation at the follow-up visit, and the total lumbar spine-related expenses of the patients up to the follow-up visit were recorded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06029764
Study type Interventional
Source Xuanwu Hospital, Beijing
Contact Hao Wu, MD,PhD
Phone 13901397527
Email 13901397527@139.com
Status Recruiting
Phase N/A
Start date February 1, 2023
Completion date January 1, 2029

See also
  Status Clinical Trial Phase
Completed NCT03859609 - Comparison of GAP-score With Schwab-score
Not yet recruiting NCT04970862 - Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration
Completed NCT03477955 - PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration N/A